Episode Details
Back to Episodes
265: Novavax's CEO promises a turnaround & how Lilly roiled the obesity market
Published 3 years, 4 months ago
Description
Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.